close

Mergers and Acquisitions

1 26 27 28 29 30 31
Number of results: 617
Date Acquired company Acquiring company Amount Related
2012-04-26 EUSA Pharma (USA) Jazz Pharmaceuticals (Ireland) $680 million (€543million) in cash plus a potential $50 million (€37.9 million) milestone payment

Oncology
Critical care

2012-04-25 Mustafa Nevzat Pharmaceuticals (Turkey) Amgen (USA) US $700 million (€ 529.4 million)

Pharmaceuticals
Hospital
Injectable medicines

2012-04-23 Pfizer Nutrition (USA) Nestlé (Switzerland) $11.85 billion (€ 9 billion)

Nutrition

2012-04-23 Ardea Biosciences (USA) AstraZeneca (UK) $1.26 billion (€ 0.95 billion)

Cancer
Oncology
Inflammatory diseases

2012-04-16 10,000,000 shares of Theravance common stock (USA) GSK (UK) $212,887,000 (€ 159861,106)
2012-04-12 Pervasis Therapeutics (USA) Shire (UK - USA) Shire will provide Pervasis with an upfront payment, plus potential post-closing milestone payments that are dependent on Shire’s achievement of certain clinical development, regulatory and sales targets.

regenerative medicine

2012-04-02 Newport Laboratories (USA) Merial (France) undisclosed

veterinary medicine

2012-03-21 Altacor (UK) NicOx (France) £2 million (approximately €2.4 million) and £9 million (approximately €10.8 million) to be paid in NicOx shares, cash or a combination of cash and shares at NicOx’s discretion.

Ophtalmology

2012-03-16 Pluromed (USA) Sanofi (France) undisclosed

Biosurgery

2012-03-15 Éclat Pharmaceuticals (USA) Flamel Technologies (France)

specialty pharmaceuticals
drug delivery

2012-03-15 FerroKin BioSciences (USA) Shire (UK - USA) up to $225 million (€171.7 million), depending upon the achievement of certain clinical development, regulatory and net sales targets

Hematology

2012-03-05 Epitomics (USA) Abcam (UK) $155 million (€117.2 million)

Antibody technologies

2012-03-01 Pierrel Research International (CRO business of Pierrel) (Italy) mondoBIOTECH (Switzerland)

CRO

2012-02-28 Anabasis (italy) Dompé (italy)

Ophtalmological diseases

2012-02-17 Amsterdam Molecular Therapeutics (The Netherlands) uniQure BV (The Netherlands)

Gene therapy

2012-02-14 Nexus Oncology (UK) Ockham (USA)

CRO

2012-01-26 Micromet (USA - Germany) Amgen (USA) $1.16 billion (€0.88 billion)

Oncology

2012-01-25 Illumina (USA) Roche (Switzerland) $6.8 billion (€5.13 million)

diagnostics
genomics

NGS

2012-01-20 Warwick Effect Polymers (UK) PolyTherics (UK) undisclosed

Protein and peptide-based drugs

2011-12-16 Topotarget USA (Topotarget’ American subsidiary division - Denmark) Apricus Biosciences (USA) up to $4 million

Cancer Oncology